Myfocept -S Tablets

Price 100.0 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

Myfocept -S Tablets Specification

Indication
Prevention of organ transplant rejection

Origin of Medicine
India

Pacakaging (Quantity Per Box)
50 tablets per box

Dosage Form
Solid

Salt Composition
Mycophenolate Sodium 360 mg

Drug Type
Allopathic

Ingredients
Mycophenolate Sodium

Physical Form
Tablets

Function
Immunosuppressant

Recommended For
Adults and Renal Transplant Patients

Dosage
As directed by physician

Dosage Guidelines
Take orally, whole without crushing or chewing

Quantity
50 tablets

Storage Instructions
Store below 25C, protect from moisture

Myfocept -S Tablets Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
Pack Of 6x10 tablets

Main Domestic Market
All India

Certifications
Myfocept-S Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.

About Myfocept -S Tablets

Specification :-

Brand Name : Myfocept-S

Content : Mycophenolate Sodium

Form : Tablets

Strength : 180 mg

Packing : Pack Of 6x10 tablets

Manufactured By-: Aprazer

Note :- Myfocept-S Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.

Effective Immunosuppressive Protection

Myfocept-S Tablets offer essential protection against organ rejection following renal transplantation. By modulating the bodys immune response, these tablets help safeguard transplanted organs, improving patient outcomes and reducing complications. The 36-month shelf life ensures long-term availability for ongoing therapy.

Directions and Safety Precautions

Take Myfocept-S Tablets exactly as prescribed by your healthcare provider. Swallow the tablet whole with water, avoiding chewing or crushing. Consistent storage below 25C and protection from moisture are necessary for medication stability. This prescription-only medicine should not be used during pregnancy, breastfeeding, or if you have hypersensitivity to its components.

FAQs of Myfocept -S Tablets:

Q: How should I take Myfocept-S Tablets for best effectiveness?

A: Take Myfocept-S Tablets orally, whole, with water. Avoid crushing or chewing them. Follow your physicians instructions carefully and never alter the dosage on your own.

Q: What are the most common side effects associated with Myfocept-S Tablets?

A: The most frequent side effects include nausea, vomiting, diarrhea, and an increased risk of infections due to the immunosuppressant nature of the medication. Consult your doctor if you experience persistent or unusual symptoms.

Q: When is it contraindicated to use Myfocept-S Tablets?

A: You should not take Myfocept-S if you are pregnant, breastfeeding, or have known hypersensitivity to mycophenolate sodium. Always inform your healthcare provider of your medical conditions before starting the medication.

Q: Where should I store Myfocept-S Tablets to ensure proper preservation?

A: Store Myfocept-S Tablets below 25C in a dry place, away from moisture and direct sunlight, to maintain their effectiveness throughout the 36-month shelf life.

Q: What is the main benefit of using Myfocept-S Tablets for renal transplant patients?

A: Myfocept-S Tablets help prevent the rejection of transplanted organs, supporting the longevity and success of the transplant by suppressing immune system activity that may target the new organ.

Q: What process should I follow if I miss a dose of Myfocept-S Tablets?

A: If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double up doses. Contact your physician for specific advice if you are unsure.

Q: Can Myfocept-S Tablets be used in pediatric patients?

A: Myfocept-S Tablets are primarily recommended for adults and renal transplant patients. Consult your physician to determine suitability if use in children is being considered.

Tell us about your requirement